Metatarsalgia Clinical Trial
— POISOfficial title:
Pressure Offloading Injectible System With the Use of Juvederm Voluma in the Foot
Verified date | May 2020 |
Source | Schoenhaus, Jodi, DPM |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The current use of Juvederm Voluma XC is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21. In this particular setting, the intended use of the product Juvederm Voluma XC is to show that the filler works to alleviate stress in high pressure areas in the foot during gait, thus decreasing foot pain and allowing individuals to walk more comfortably.
Status | Active, not recruiting |
Enrollment | 29 |
Est. completion date | January 30, 2021 |
Est. primary completion date | April 30, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility |
Inclusion Criteria: - Patient's 40 to 75 years of age - Foot and ankle disability index of at least 55 (based on the majority of people having moderate difficulty in weight-bearing living) and heavy clinical significance of fat atrophy as evaluated by the principal investigator creating a standard analysis. - Atrophy of the heel or the ball of the foot will be evaluated in the step wise approach. - Second a clinical exam by the primary investigator Exclusion Criteria: - Patients who do not have high pressure fat pad atrophy - Patient is being treated for cancer - Skin infections - Unhealed or acute foot fractures - Patients with a decrease in dorsalis pedis or posterior tibial pulses - Pregnant or breast-feeding - Patients who have had previous injections with fillers - Patients with nerve injury or nerve damage to the foot causing symptoms of numbness, tingling, burning, and sharp shooting or stabbing sensations. This criteria shall be determined by a. direct patient feedback. If the patient verbally states that they have numbness tingling burning sharp shooting or stabbing pains in their feet or ankles they will not be included. b. Semmes Weinstein Monofilament Testing - Semmes Weinstein monofilament testing will be performed on all patients. The Semmes Weinstein will be performed on the great toe submetatarsal one submetatarsal three submetatarsal five the heel and the dorsum of the foot. If a patient cannot feel the sends Weinstein filament in any of those locations they will be eliminated. - Active an acute diabetic foot ulceration - Patients with severe allergies manifested by history of anaphylaxis - Patients with a history or presence of multiple severe allergies - Patients with a history of allergies to gram-positive bacterial proteins - Patients with a history of allergies to lidocaine. |
Country | Name | City | State |
---|---|---|---|
United States | Foot, Ankle & Leg Vein Center | Boca Raton | Florida |
Lead Sponsor | Collaborator |
---|---|
Schoenhaus, Jodi, DPM |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | AOFAS | The primary endpoint is 12 weeks post injection. The endpoint will be evaluated by the foot and ankle outcome questionnaire for improvement of pain scale scores and ability to return to activity. An improvement that is statistically relevant will be considered an overall total improvement | 12 weeks | |
Secondary | Less pressure | Follow up evaluations: week two, week 24, and week 52. Follow-up evaluation includes: gate pressure mapping with an improvement being a statistically relevant improvement in peek pressure scores before and after treatment | 52 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05555459 -
Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation
|
N/A | |
Completed |
NCT05579054 -
Translation, Validity, and Reliability of the Foot Posture Index (FPI-6) - Turkish Version
|
||
Completed |
NCT04941469 -
Effectiveness of Specifically Optimized Off-the-counter Foot Orthosis for the Subtle Cavus Foot
|
N/A | |
Completed |
NCT04949685 -
Evaluation of Clinical and Functional Results After Operative Correction of Lesser Toe Deformities
|
||
Completed |
NCT02369380 -
Volume Restoration of Plantar Pad With a Hyaluronic Acid Dermal Filler in Metatarsalgia
|
N/A | |
Recruiting |
NCT05262972 -
Percutaneous Needle Electrolysis on Metatarsalgia
|
N/A | |
Recruiting |
NCT02843672 -
Operative Treatment Of Metatarsalgia: Triple Weil Osteotomy Or Distal Metatarsal Minimal Invasive Osteotomy (DMMO)?
|
N/A | |
Completed |
NCT05713175 -
Orthopaedic Treatment in Propulsive Metatarsalgia
|
N/A | |
Completed |
NCT04697914 -
The Effect of a Discharge Sock Model in Comfort: Randomized Controlled Trial
|
N/A | |
Completed |
NCT02578615 -
Physiotherapy for Chronic Metatarsalgia
|
N/A | |
Active, not recruiting |
NCT06350435 -
Effects of Prefabricated Foot Orthoses With and Without Metatarsal Pads on Central Metatarsalgia
|
N/A | |
Completed |
NCT02667990 -
Maximal Plantar Pressure and Comfort Evaluation of Orthopedic Stilettos
|
N/A | |
Completed |
NCT01629173 -
The Analysis and Applications of Dynamic Impression Insole
|
Phase 0 | |
Completed |
NCT03482518 -
Effectiveness of Postural Insoles Adapted in Slippers for People With Persistent Heel Pain
|
N/A |